Table 3.
Distribution of mean HRC values based on the study of 17 qualitative morpho-physiological traits in CAD patients and control sample regarding presence and number of risk factors.
| RF | HRC (MV ± SD) | (p) ** | HRC, V (%) | ||
|---|---|---|---|---|---|
| Control Sample | CAD Patients | Control Sample | CAD Patients | ||
| 0 | 4.63 ± 1.38 | 0 | - | 29.81 | 0 |
| 1 | 4.13 ± 1.68 | 4.75 ± 2.18 | 0.569 | 39.47 | 45.89 |
| 2 | 3.48 ± 1.82 | 3.88 ± 1.50 | 0.211 | 52.30 | 38.66 |
| 3 | 3.15 ± 1.54 | 4.65 ± 1.56 | <0.001 | 48.89 | 33.55 |
| 4 | 3.92 ± 1.31 | 3.97 ± 1.40 | 0.920 | 33.42 | 35.26 |
| (p) * | (0.007) | (0.040) | - | - | - |
| A *** | 0.004 | ||||
| B *** | 0.009 | ||||
| C *** | 0.057 | ||||
RF: Risk factors; HRC: Homozygously-recessive characteristics; CAD: Coronary artery disease; MV: Mean value; SD: Standard deviation; V: Variability; * Unifactorial ANOVA; ** Mann-Whitney U test; *** Two-way ANOVA; A: Presence of CAD and frequencies distribution of HRCs; B: number of RF and frequencies distribution of HRCs; C: presence of CAD and number of RFs interaction, and frequencies distribution of HRCs.